BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren X, Trilesskaya M, Kwan DM, Nguyen K, Shaw RE, Hui PY. Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection. Am J Cardiol 2009;104:216-22. [PMID: 19576350 DOI: 10.1016/j.amjcard.2009.03.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Escárcega RO, Franco JJ, Mani BC, Vyas A, Tedaldi EM, Bove AA. Cardiovascular disease in patients with chronic human immunodeficiency virus infection. International Journal of Cardiology 2014;175:1-7. [DOI: 10.1016/j.ijcard.2014.04.155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
2 Ebner B, Vincent L, Grant J, Martinez C. Cardiac Catheterization Procedures in Patients with HIV: A Retrospective Analysis. J Cardiovasc Dev Dis 2021;8:33. [PMID: 33801600 DOI: 10.3390/jcdd8040033] [Reference Citation Analysis]
3 Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61:511-523. [PMID: 23369416 DOI: 10.1016/j.jacc.2012.06.063] [Cited by in Crossref: 181] [Cited by in F6Publishing: 167] [Article Influence: 20.1] [Reference Citation Analysis]
4 Sinha A, Feinstein MJ. Coronary Artery Disease Manifestations in HIV: What, How, and Why. Can J Cardiol 2019;35:270-9. [PMID: 30825949 DOI: 10.1016/j.cjca.2018.11.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
5 Bundhun PK, Pursun M, Huang WQ. Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017;17:190. [PMID: 28716008 DOI: 10.1186/s12872-017-0624-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
6 Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, Chauvet M, Ederhy S, Dufour-Soulat L, Ancedy Y, Nhan P, Adavane S, Steg PG, Funck-Brentano C, Costagliola D, Cohen A; PACS‐HIV (Prognosis of Acute Coronary Syndrome in HIV‐Infected Patients) Investigators †. HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome. J Am Heart Assoc 2020;9:e017578. [PMID: 32844734 DOI: 10.1161/JAHA.119.017578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Volpe M, Uglietti A, Castagna A, Mussini C, Marchetti G, Bellagamba R, Bini T, Mancusi D, Termini R. Cardiovascular disease in women with HIV-1 infection. Int J Cardiol 2017;241:50-6. [PMID: 28285796 DOI: 10.1016/j.ijcard.2017.02.117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mondal P, Aljizeeri A, Small G, Malhotra S, Harikrishnan P, Affandi JS, Buechel RR, Dwivedi G, Al-Mallah MH, Jain D. Coronary artery disease in patients with human immunodeficiency virus infection. J Nucl Cardiol 2021;28:510-30. [PMID: 32820424 DOI: 10.1007/s12350-020-02280-4] [Reference Citation Analysis]
9 Xue L, Dai S, Li Z. Synthesis and characterization of elastic star shape-memory polymers as self-expandable drug-eluting stents. J Mater Chem 2012;22:7403. [DOI: 10.1039/c2jm15918j] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
10 Schneider S, Spinner CD, Cassese S, Promny D, Hapfelmeier A, Byrne RA, Baumann M, Jäger H, Steinlechner E, Laugwitz KL, Kastrati A. Association of increased CD8+ and persisting C-reactive protein levels with restenosis in HIV patients after coronary stenting. AIDS 2016;30:1413-21. [PMID: 26891035 DOI: 10.1097/QAD.0000000000001063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, Touzery C, Hamblin J, Gudjoncik A, Cottin Y, Quantin C. Outcomes After Acute Myocardial Infarction in HIV-Infected Patients: Analysis of Data From a French Nationwide Hospital Medical Information Database. Circulation 2013;127:1767-74. [DOI: 10.1161/circulationaha.113.001874] [Cited by in Crossref: 85] [Cited by in F6Publishing: 35] [Article Influence: 9.4] [Reference Citation Analysis]
12 Costiniuk CT, Hibbert BM, Simard T, Ghazawi FM, Angel JB, O’brien ER. Circulating endothelial progenitor cells in HIV infection: A systematic review. Trends in Cardiovascular Medicine 2013;23:192-200. [DOI: 10.1016/j.tcm.2012.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
13 Tsiodras S, Mantzoros CS. Drug-drug interactions in HIV medicine: a not so simple and straightforward road to the future. Metabolism 2011;60:1497-9. [DOI: 10.1016/j.metabol.2011.05.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation 2019;140:e98-e124. [PMID: 31154814 DOI: 10.1161/CIR.0000000000000695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
15 Liu Y, Chen Y, Hao Y, Xiao J, Li B, Zhang L, Han J, Zhao H, Nguyen TN. Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China. Journal of Interventional Cardiology 2022;2022:1-8. [DOI: 10.1155/2022/8351304] [Reference Citation Analysis]
16 Tsabedze N, Vachiat A, Zachariah D, Manga P. A New Face of Cardiac Emergencies: Human Immunodeficiency Virus-Related Cardiac Disease. Cardiol Clin 2018;36:161-70. [PMID: 29173676 DOI: 10.1016/j.ccl.2017.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
17 Feinstein MJ, Poole B, Engel Gonzalez P, Pawlowski AE, Schneider D, Provias TS, Palella FJ, Achenbach CJ, Lloyd-Jones DM. Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing. J Nucl Cardiol 2018;25:872-83. [PMID: 27739037 DOI: 10.1007/s12350-016-0689-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Ng B, Macpherson P, Haddad T, Dwivedi G. Heart failure in HIV infection: focus on the role of atherosclerosis. Current Opinion in Cardiology 2014;29:174-9. [DOI: 10.1097/hco.0000000000000041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Vachiat A, Mccutcheon K, Tsabedze N, Zachariah D, Manga P. HIV and Ischemic Heart Disease. Journal of the American College of Cardiology 2017;69:73-82. [DOI: 10.1016/j.jacc.2016.09.979] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
20 Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol 2019;16:745-59. [PMID: 31182833 DOI: 10.1038/s41569-019-0219-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
21 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
22 Bernelli C, Danzi GB, Cerrato E, Pierini S, Ornaghi MG, Botta L, Gentile F, Migliorino GM, Squillace N. Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease. Can J Cardiol 2020;36:127-34. [PMID: 31813674 DOI: 10.1016/j.cjca.2019.07.636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 McCutcheon K, Triantafyllis AS, Van den Eynde J, Oosterlinck W, Vachiat A, Tsabedze N, Zachariah D, Manga P, Bennett J. Coronary revascularization in patients with HIV. Trends Cardiovasc Med 2021:S1050-1738(21)00027-X. [PMID: 33626383 DOI: 10.1016/j.tcm.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Demir OM, Candilio L, Fuster D, Muga R, Barbaro G, Colombo A, Azzalini L. Cardiovascular disease burden among human immunodeficiency virus-infected individuals. Int J Cardiol 2018;265:195-203. [PMID: 29885686 DOI: 10.1016/j.ijcard.2018.03.137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
25 Badr S, Minha S, Kitabata H, Fatemi O, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus: PCI in Patients with HIV. Cathet Cardiovasc Intervent 2015;85:192-8. [DOI: 10.1002/ccd.25466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
26 Fisher SD, Kanda BS, Miller TL, Lipshultz SE. Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients: . American Journal Cardiovascular Drugs 2011;11:383-94. [DOI: 10.2165/11594590-000000000-00000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
27 Seecheran R, Seecheran V, Persad S, Dookie T, Seecheran NA. Atypical presentation of critical left main disease in an HIV-infected patient. Int Med Case Rep J 2018;11:139-43. [PMID: 29950906 DOI: 10.2147/IMCRJ.S164642] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Shah MR, Cook N, Wong R, Hsue P, Ridker P, Currier J, Shurin S. Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease. J Am Coll Cardiol 2015;65:738-44. [PMID: 25677433 DOI: 10.1016/j.jacc.2014.12.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
29 D’Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Bollati M, Modena MG, Gaita F, Sheiban I. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J. 2012;33:875-880. [PMID: 22187508 DOI: 10.1093/eurheartj/ehr456] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
30 Albaeni A, Harris C, Eid SM, Abougergi MS, Wright SM. HIV status and type of coronary stent placed in patients presenting with ST-elevation myocardial infarction. Coron Artery Dis 2017;28:239-45. [PMID: 28288008 DOI: 10.1097/MCA.0000000000000488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
31 Moran CA, Southmayd G, Devireddy CM, Quyyumi AA, Ofotokun I, Liberman HA, Jaber W, Sheth AN. Clinical and procedural characteristics of persons living with HIV presenting with acute coronary syndrome. AIDS 2020;34:81-90. [PMID: 31634195 DOI: 10.1097/QAD.0000000000002393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Parks MM, Secemsky EA, Yeh RW, Shen C, Choi E, Kazi DS, Hsue PY. Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection. Eur Heart J Qual Care Clin Outcomes 2021;7:273-9. [PMID: 33226071 DOI: 10.1093/ehjqcco/qcaa088] [Reference Citation Analysis]
33 Costiniuk CT, Hibbert BM, Filion LG, Kovacs CM, Benko E, O'Brien ER, Angel JB. Circulating endothelial progenitor cell levels are not reduced in HIV-infected men. J Infect Dis 2012;205:713-7. [PMID: 22238473 DOI: 10.1093/infdis/jir836] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]